
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
The Long Run with Luke Timmerman
00:00
Is There an Opportunity to Invest in Basic Research?
I think right now, latem, that farmer might be getting a little bit of a break on the drug pricing thing. They were at the bottom of the barrel on reputation at the beginning of this pandemic. Now some poles are showing that people are starting to think farma maybe not as bad as we once thought. Do you think there's an opportunity here to, like, you don't really press on the gas and hold on to competitive advantage in the united states?
Transcript
Play full episode